StockData
Alto Neuroscience, Inc. logo

Alto Neuroscience, Inc. (ANRO) income statement

ANRONYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 4/30
$25.37−1.14 (-4.30%)

Close on Nov 20, 2026Market cap $995.57MP/E –Yield –

See a number that looks wrong?